Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mobileye, BioVie, ADM, and B. Riley and Encourages Investors to Contact the Firm
Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
- Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
- Upon trial completion, the Company found significant deviation from protocol and Good Clinical Practice (GCP) violations at 15 sites.
- As alleged, Defendants’ accounting practices for the segment misrepresented its true financial results and prospects, including its operating profits (“OP”).
- For more information on the B. Riley class action go to: https://bespc.com/cases/RILY